Author | Peter W. Stalmans, MD

Articles

Ocriplasmin success based on proper patient selection

Real-world experience with ocriplasmin indicates it is an effective, safe, and cost-effective treatment for symptomatic vitreomacular adhesion in properly selected eyes.

New content coming soon, please check back later.